Literature DB >> 34931329

Can COVID-19 cause atypical forms of pityriasis rosea refractory to conventional therapies?

Fabrizio Martora1, Vincenzo Picone1, Luigi Fornaro1, Gabriella Fabbrocini1, Claudio Marasca1.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34931329     DOI： 10.1002/jmv.27535

Source DB:  PubMed          Journal:  J Med Virol        ISSN： 0146-6615            Impact factor:   20.693


× No keyword cloud information.
  4 in total

1.  COVID-19-associated pityriasis rosea in children: Case report and literature review.

Authors:  Maryam Khalili; Bahareh Abtahi-Naeini; Fereshte Rastegarnasab; Kimia Afshar
Journal:  Clin Case Rep       Date:  2022-07-19

2.  Impact of COVID-19 on Clinicopathological Spectrum of Pityriasis Rosea in Korea.

Authors:  Dai Hyun Kim; Jun Hyuk Cho; Sung Jin Park; Soo Hong Seo; Hyo Hyun Ahn
Journal:  J Korean Med Sci       Date:  2022-06-20       Impact factor: 5.354

3.  Pityriasis rosea during COVID-19: Pathogenesis, diagnosis, and treatment.

Authors:  Giulia Ciccarese; Francesco Drago; Eugenio Marinaro; Aurora Parodi
Journal:  J Med Virol       Date:  2022-03-06       Impact factor: 20.693

4.  Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.

Authors:  Fabrizio Martora; Vincenzo Picone; Teresa Battista; Gabriella Fabbrocini; Claudio Marasca
Journal:  Dermatol Ther       Date:  2022-06-13       Impact factor: 3.858
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.